CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,117,000 | -10.3% | 40,100 | +15.6% | 0.27% | -13.8% |
| Q4 2017 | $2,360,000 | -2.6% | 34,700 | +18.0% | 0.31% | +11.8% |
| Q3 2017 | $2,423,000 | +25.0% | 29,400 | +42.0% | 0.28% | +33.5% |
| Q2 2017 | $1,938,000 | +353.9% | 20,700 | +209.0% | 0.21% | +335.4% |
| Q1 2017 | $427,000 | – | 6,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |